Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: France,Poland,Germany,Czech Republic,Ukraine,Australia,United States,Canada,Italy,New Zealand
nct
MAJ Il y a 5 ans
Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
The purpose of the study is to evaluate the clinical efficacy, safety and tolerability of apremilast (30 mg twice daily [BID] and 40 mg BID), compared with placebo, in subjects with active Ulcerative Colitis (UC).
Pays
Australia
,
Bulgaria
,
Canada
,
Czech Republic
,
France
,
Germany
,
Hungary
,
Italy
,
Netherlands
,
New Zealand
,
Poland
,
Russian Federation
,
Ukraine
,
United States
,
Organes
Aucun
Spécialités
Aucun
Essai ouvert aux inclusions
Plus d'informations
1